Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study

OBJECTIVE: Ischemia-modified albumin (IMA) is a sensitive biomarker of myocardial ischemia. However, data on IMA levels in acute heart failure (HF) are still lacking. In this study, we aimed to evaluate serum IMA levels in acute decompensated HF and the effects of dobutamine and levosimendan treatme...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Anatol J Cardiol
Prif Awduron: Çavuşoğlu, Yüksel, Korkmaz, Şule, Demirtaş, Selda, Gencer, Erkan, Şaşmaz, Hatice, Mutlu, Fezan, Güneş, Hakan, Mert, Uğur Kadir, Özdemir, Sedat, Kalaycı, Süleyman, Yılmaz, Mehmet Birhan
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Kare Publishing 2016
Pynciau:
Original Investigation
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5336859/
https://ncbi.nlm.nih.gov/pubmed/26301344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/akd.2015.6156
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg